Cellect Biotechnology Ltd. (NASDAQ:APOP) shares, rose in value on Wednesday, 07/21/21, with the stock price up by 5.10% to the previous day’s close as strong demand from buyers drove the stock to $4.33.
Actively observing the price movement in the last trading, the stock closed the session at $4.12, falling within a range of $4.14 and $4.83. The value of beta (5-year monthly) was 1.81. Referring to stock’s 52-week performance, its high was $7.15, and the low was $1.65. On the whole, APOP has fluctuated by 17.98% over the past month.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that APOP’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
1 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 0 analyst(s), 1 recommend it as a Buy and 0 called the APOP stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of APOP currently trading nearly 14.08% and 29.10% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 64.17, while the 7-day volatility ratio is showing 11.07% which for the 30-day chart, stands at 9.36%. Furthermore, Cellect Biotechnology Ltd. (APOP)’s average true range (ATR) is 0.44. The company’s stock has been forecasted to trade at an average price of $3.00 over the course of the next 52 weeks, with a low of $3.00 and a high of $3.00. Based on these price targets, the low is 30.72% off current price, whereas the price has to move 30.72% to reach the yearly target high. Additionally, analysts’ median price of $3.00 is likely to be welcomed by investors because it represents an increase of 30.72% from the current levels.
Data on historical trading for Cellect Biotechnology Ltd. (NASDAQ:APOP) indicates that the trading volumes over the past 10 days have averaged 1.08 million and over the past 3 months, they’ve averaged 1.83 million. According to company’s latest data on outstanding shares, there are 3.91 million shares outstanding.
Nearly 8.03% of Cellect Biotechnology Ltd.’s shares belong to company insiders and institutional investors own 16.58% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.11 million shares as on May 27, 2021, resulting in a short ratio of 0.18. According to the data, the short interest in Cellect Biotechnology Ltd. (APOP) stood at 2.79% of shares outstanding as of May 27, 2021; the number of short shares registered in Apr 29, 2021 reached 97180.0. The stock has risen by 100.46% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the APOP stock heading into the next quarter.